Cannabis Strategic Ventures, Inc. (OTC: NUGS) this morning announced its appointment of Robert H. Cohen M.D. to the position of medical advisor in support of the further development and research of Halo Filters and other CBD-related brands. Per the update, Cohen is a cannabis researcher and highly qualified cosmetic surgeon based in California. His involvement in the cannabis field dates back to 2007, when he helped perform medical evaluations for the use of medical marijuana in California, and he has continued to assist with researching the properties of CBD and the derivatives of medical marijuana for skincare and overall well-being in the years since. “Dr. Cohen is a great addition to the NUGS family. His medical expertise will help us continue to improve our products and communicate the health importance related to Cannabis,” Simon Yu, CEO of Cannabis Strategic, stated in the news release. “His cannabis research expertise will advance Halo Filters as well as our family of brands.”
To view the full press release, visit http://cnw.fm/0EFai
About Cannabis Strategic Ventures, Inc.
Cannabis Strategic Ventures is based in Los Angeles and is focused on supporting entrepreneurial growth within the fast-growing legal cannabis sector. The Company recently completed a name and symbol change from Cascade Energy, Inc. Cannabis Strategic Ventures offers outsourced personnel solutions that are tailor made to match the growth dynamics of cannabis cultivators, manufacturers, dispensaries, and other cannabis marketplace participants. Cannabis Strategic Ventures is publicly traded on the U.S. Over the Counter Market with the stock symbol NUGS. For more information, visit the company’s website at www.CannabisStrategic.com
More from CannabisNewsBreaks
About HempWire
HempWire (HW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) HempNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, HW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. HW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, HW brings its clients unparalleled visibility, recognition and brand awareness. HW is where news, content and information converge.
For more information please visit https://www.hempwire.com
Please see full terms of use and disclaimers on the HempWire website applicable to all content provided by HW, wherever published or re-published: https://www.hempwire.com/disclaimer/
HempWire (HW)
Denver, Colorado
www.hempwire.com
303.498.7722 Office
Editor@HempWire.net
Golden Triangle Ventures (OTC: GTVH) (“GTV”) has completed a major restructuring of its capital structure and…
InMed Pharmaceuticals (NASDAQ: INM), a pharmaceutical company developing small molecule drug candidates for diseases with…
CannabisNewsWire (CNW), a trusted communications platform within the cannabis sector and a part of InvestorBrandNetwork…
Turning Point Brands (NYSE: TPB), a manufacturer, marketer and distributor of branded consumer products, recently…
WEED Inc. (OTCQB: BUDZ), a global cannabis and hemp bioresearch company based in the U.S.,…
Flora (NASDAQ: FLGC) has closed a registered direct offering to institutional investors for the aggregate…